Volume 14; Issue supp-S1

Main
European Neuropsychopharmacology
Volume 14; Issue supp-S1

European Neuropsychopharmacology

Volume 14; Issue supp-S1

1

S.1.1 Genetic evidence that the amounts of pathogenic proteins matter in the pathogeneses of Alzheimer's and Parkinson's diseases

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 49 KB

english, 2004

2

S.1.2 Pharmacogenetics in the treatment of schizophrenia

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 55 KB

english, 2004

3

P.1.01 The role of neurogenesis in addiction and depression

S. Brené, E. Åberg, A. Bjørnebekk, C. Hofstetter, A.A. Mathé, L. Olson

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 51 KB

english, 2004

4

P.1.02 Chronic cocaine treatment induces ΔFosB expression and accumulation in CRH-positive neurons of the rat paraventricular nucleus of hypothalamus

A. Chocyk, K. Wȩdzony

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 60 KB

english, 2004

5

P.1.03 Constitutive activity of the recombinant and native histamine H3 receptor: effects of inverse agonists and protean agonists

F. Gbahou, A. Rouleau, S. Morisset, X. Ligneau, J. Tardivel-Lacombe, R. Parmentier, S. Crochet, J.S. Lin, H. Stark, W. Schunack, C.R. Ganellin, J.C. Schwartz, J.M. Arrang

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 59 KB

english, 2004

6

P.1.04 Interactions of GIPC with dopamine D2, D3 but not D4 receptors define a novel mode of regulation of G protein-coupled receptors

F. Jeanneteau, O. Guillin, J. Diaz, P. Sokoloff, N. Griffon

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 50 KB

english, 2004

7

P.1.05 HTR2C (cys23ser) polymorphism influences early onset in bipolar patients in a large European multicenter genetic association study

I. Massat, P. Oswald, D. Souery, D. Blackwood, R. Kaneva, B. Lerer, M. Nöthen, L. Oruc, G.N. Papadimitriou, A. Serretti, C. Van Broeckhoven, J. Mendlewicz

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 41 KB

english, 2004

8

P.1.06 Brain-derived neurotrophic factor (BDNF) gene in unipolar affective disorder: a Belgian patient-control association study

P. Oswald, J. Del-Favero, I. Massat, D. Souery, S. Claes, C. Van Broeckhoven, J. Mendlewicz

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 41 KB

english, 2004

9

P.1.07 Gene expression profiling to identify new targets associated with schizophrenia and its treatment

M. Parsons, D.T. Mancama, M.J. Arranz, R.W. Kerwin

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 54 KB

english, 2004

10

P.1.08 Endothelial nitric oxide synthase (NOS-III) knockout differentially affects the regulation of adult neurogenesis in mice

A. Reif, A. Schmitt, S. Fritzen, C. Bartsch, C. Sommer, K.-P. Lesch

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 47 KB

english, 2004

11

P.1.09 Effect of desipramine on the transcriptional activity of the dopamine D2 receptor gene promoter in the Neuro-2a cell line

J. Solich, M. Dziedzicka-Wasylewska

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 51 KB

english, 2004

12

P.1.10 Diverse psychotomimetics act through a common signaling pathway

P. Svenningsson, E.T. Tzavara, A.A. Fienberg, G.G. Nomikos, P. Greengard

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 58 KB

english, 2004

13

P.1.11 Selective effects of antidepressants on CREB phosphorylation and related kinase cascade

E. Tiraboschi, S. Moraschi, D. Tardito, J. Kasahara, M. Gennarelli, G. Racagni, M. Popoli

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 50 KB

english, 2004

14

P.1.12 Functional role of galanin and its receptors in hippocampal synaptic plasticity: Electrophysiological studies on transgenic mice

Z.-Q.D. Xu, K. Zheng, M. Kokaia, S. Xia, S. Kjaer, P.-S. Hu, E. Kuteeva, T. Xu, T. Bartfai, T. Hökfelt

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 57 KB

english, 2004

15

P.1.13 Preliminary characterization of the platelet dopamine transporter in human blood platelets

S. Baroni, I. Masala, L. Betti, L. Fabbrini, P. Italiani, G. Giannaccini, F. Mungai, D. Marazziti

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 50 KB

english, 2004

16

P.1.14 Neurobiological and behavioral effects of chronic mild stress in glucocorticoid receptor-impaired transgenic mice

N. Froger, C. Boni, N. Hanoun, C. Joubert, I. Dutriez-Casteloot, N. Barden, C. Cohen-Salmon, M. Hamon, L. Lanfumey

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 44 KB

english, 2004

17

P.1.15 GABA receptor modulation of 5-HT neuronal firing in the dorsal raphe nucleus and its sensitivity to moderate variations in corticosterone levels

S. Judge, C.D. Ingram, S.E. Gartside

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 61 KB

english, 2004

18

P.1.16 Association between serotonin-related genetic polymorphisms and cholecystokinin tetrapeptide induced panic attacks in healthy volunteers

E. Maron, G. Tasa, I. Tõru, A. Lang, V. Vasar, J. Shlik

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 61 KB

english, 2004

19

P.1.17 Separate and combined effects of fluoxetine and a 5-HT1A receptor agonist or antagonist on 5-HT1A and 5-HT1B autoreceptor activity in the rat brain

G. Shalom, E. Gur, L.D. Van de Kar, B. Lerer, M.E. Newman

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 61 KB

english, 2004

20

P.1.18 Inositol monophosphatase, 3′-phosphoadenosine 5′-phosphate phosophatase and glycogen synthase kinase-3 are less active in human brain than rat brain

G. Shaltiel, N. Kozlovsky, G. Agam, S. Marcu, E. Reichental, R.H. Belmaker

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 59 KB

english, 2004

21

P.1.19 Effect of chronic lithium and valproate treatment on gene expression of inositol-producing enzymes

A. Shamir, R.H. Belmaker, G. Agam

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 52 KB

english, 2004

22

P.1.20 Fluoxetine pretreatment affects pentylenetetrazol-induced neuronal activation in the rat hippocampus

M. Zienowicz, A. Wisłowska, E. Taracha, M. Lehner, A. Skórzewska, P. Maciejak, A. Płaźnik

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 49 KB

english, 2004

23

S.2.1 Neuromodulators at the behavioral level

S.O. Ögren, A. Kuzmin, J. Sandin, O. Stiedl

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 54 KB

english, 2004

24

S.2.2 Neuropsychopharmacology: bridging animal and human studies

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 57 KB

english, 2004

25

P.2.01 Anxiogenic drugs act selectively on topographically distinct midbrain, pontine, and medullary serotonergic neurones

J.K. Abrams, P.L. Johnson, A. Shekhar, C.A. Lowry

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 50 KB

english, 2004

26

P.2.02 Effects of naltrexone, naltrindole and U50,488H on the initiation of intravenous cocaine self-administration in drug naïve mice

E.A. Blokhina, A.Y. Bespalov, E.E. Zvartau

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 57 KB

english, 2004

27

P.2.03 Effects of fluvoxamine on HPA-axis reactivity in transgenic mice overexpressing corticotropin-releasing factor

A. Dirks, B. Olivier, J. van der Gugten, T. Tuinstra, L. Groenink

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 57 KB

english, 2004

28

P.2.04 Hypothalamic histochemistry in different genetic models of anorexia

S.O. Fetissov, J.E. Johansen, C. Broberger, L.C. Byrne, Z. Zhou, M. Schalling, B. Ranscht, K. Tryggvason, T. Hökfelt

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 55 KB

english, 2004

29

P.2.05 Effects of early life experience on behaviour during social defeat and subsequent changes in serotonergic and non-serotonergic neurones within the dorsal raphe nucleus (DRN)

K.L. Gardner, S.L. Lightman, P.M. Plotsky, C.A. Lowry

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 51 KB

english, 2004

30

P.2.06 Leptin treatment in activity-based anorexia

J. Hillebrand, M. Kas, A. Scheurink, G. van Dijk, R. Adan

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 60 KB

english, 2004

31

P.2.07 The nucleus accumbens and cocaine self-administration: dissociating the role of core and shell sub-regions

R. Ito, T.W. Robbins, B.J. Everitt

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 49 KB

english, 2004

32

P.2.08 Acute hypercapnic gas challenge increases c-Fos in topographically organised histaminergic neurones

P.L. Johnson, R. Moratalla, S.L. Lightman, C.A. Lowry

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 44 KB

english, 2004

33

P.2.09 Limbic Crhr1 mediates anxiety-related behaviour and is required for hormonal adaptation to stress

M.B. Müller, S. Zimmermann, I. Sillaber, T.P. Hagemeyer, J.M. Deussing, S. Droste, J.H.M.H. Reul, F. Holsboer, W. Wurst

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 55 KB

english, 2004

34

P.2.10 Monoaminergic neurotransmission in sleep-wake promoting brain areas: Effects of sleep deprivation and the GABAA receptor antagonist bicuculline

R.G. Peñalva, C. Flachskamm, A.C.E. Linthorst

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 60 KB

english, 2004

35

P.2.11 Identification of GABAA receptor subtypes involved in tolerance against the sedative action of diazepam

C. van Rijnsoever, M. Täuber, U. Rudolph, J.M. Fritschy, F. Crestani

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 51 KB

english, 2004

36

P.2.12 Interaction between metabotropic glutamate 5 receptors and NPY in the amygdala as a novel mechanism of anxiolysis

J. Wieronska, M. Śmiałowska, P. Brański, A. Kłodzińska, B. Szewczyk, A. Pałucha, E. Chojnacka-Wojcik, A. Pilc

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 58 KB

english, 2004

37

P.2.13 Co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex: implication for the neurobiology of psychiatric disorders

A. Zuddas, P. Devoto, G.L. Gessa

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 50 KB

english, 2004

38

P.2.14 The effects of ibuprofen and curcumin on spatial working memory following an injection of aggregated Beta-amyloid(1–42) into the CA3 area of the rat hippocampus

T.C. Ardis, P. Stacey, E.-M. Kim, E. O'Hare

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 43 KB

english, 2004

39

P.2.15 Olanzapine, but not haloperiool, improves cognitive performance in an animal model of amnesia induced by β-amyloid peptides

D. Consoli, V. Micale, C. Mazzola, F. Drago

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 45 KB

english, 2004

40

P.2.16 ACTH(4–10) analogue SEMAX attenuates opioid-induced analgesia

D.M. Ivanova, D.A. Vilensky, N.G. Levitskaya, L.A. Andreeva, A.A. Kamensky

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 52 KB

english, 2004

41

P.2.17 Antenatal hypoxia influence on the development of CNS

A.V. Graf, M.V. Maslova, A.S. Maklakova, N.A. Sokolova, E.N. Goncharenko, A.A. Bayzhymanov, M.Sh. Avruschenko

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 58 KB

english, 2004

42

P.2.18 Comparison of NK1−/− and NK1+/+ mice in a light/dark shuttle-box and effects of the antidepressant desipramine

I. Herpfer, S.P. Hunt, S.C. Stanford

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 50 KB

english, 2004

43

P.2.19 Efference copy. The motoric command for head bobbing in pigeons

I.T. Nathaniel, N. Troje, O. Güntürkün, M. Manns

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 57 KB

english, 2004

44

P.2.20 Nicotine antagonizes caffeine-induced but not pentylenetetrazole-induced anxiogenic effect in mice

H. Kayir, I.T. Uzbay

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 55 KB

english, 2004

45

P.2.21 Phencyclidine increases prepulse inhibition of acoustic startle in neuronal nitric oxide synthase deficient mice

D. Klamer, J.A. Engel, L. Svensson

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 54 KB

english, 2004

46

P.2.22 The influence of selective agonists at cannabinoid CB1 receptor and CB2 receptor on sensitization to methamphetamine behavioural effects in mice

L. Landa, K. Slais, A. Sulcova

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 40 KB

english, 2004

47

P.2.23 Habenula lesion causes attention deficits in rats: implications for cognition and schizophrenia

L. Lecourtier, P.H. Kelly

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 41 KB

english, 2004

48

P.2.24 The effects of acute hypoxia on the regional cerebral blood flow: peptidergic correction

M.V. Maslova, A.V. Graf, A.S. Maklakova, N.A. Sokolova

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 52 KB

english, 2004

49

P.2.25 GABAB receptors play a key role in the modulation of anxiety and antidepressant-related behaviour: genetic and pharmacological evidence

C. Mombereau, K. Kaupmann, W. Froestl, H. Van Der Putten, J.F. Cryan

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 63 KB

english, 2004

50

P.2.26 Effect of interferon-α treatment on behaviour and immunity

A.-M. Myint, S. O'Mahony, M. Kubera, A. Basta

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 55 KB

english, 2004

51

P.2.27 Topographical evaluation of spontaneous and agonist-induced behaviour in mutants with congenic dopamine D4 versus D5 receptor knockout

G.J. O'Sullivan, D.T. Croke, O. Tighe, A. Kinsella, D.K. Grandy, M.J. Low, M. Rubinstein, D.R. Sibley, J.L. Waddington

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 41 KB

english, 2004

52

P.2.28 Antidepressant-like effects of tiagabine on locomotor/exploratory behaviour and leukocyte phagocytosis in rats

J. Pistovcakova, A. Sulcova

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 61 KB

english, 2004

53

P.2.29 Lesion of serotonin system in the early period after birth — behavioral consequences in adult animals

P. Rok-Bujko, P. Krzascik, W. Kostowski

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 60 KB

english, 2004

54

P.2.30 Evidence for reduced anxiety in mice lacking CCK2 receptors

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 47 KB

english, 2004

55

S.3.1 Imaging in clinical research — Perspectives on time and functional analysis

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 46 KB

english, 2004

56

S.3.2 Progressive brain changes in schizophrenia as an endophenotype

R.S. Kahn, H.E. Hulshoff Pol, W. Cahn, N. van Haaren, H. Schnack, R. Mandl

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 61 KB

english, 2004

57

P.3.01 Increased brain volumes in medication naive high-functioning subjects with autism

S. Palmen, H.E. Hulshoff Pol, C. Kemner, H.G. Schnack, R.S. Kahn, H. van Engeland

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 47 KB

english, 2004

58

P.3.02 Personality traits as predictors of treatment response in patient with affective disorder

S. Linotte, P. Oswald, I. Massat, D. Souery, S. Kasper, Y. Lecrubier, J. Zohar, J. Mendlewicz

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 54 KB

english, 2004

59

P.3.03 An fMRI study of executive function in first episode schizophrenia

P. Matthiasson, M. Picchioni, P. Power, S. Williams, P. McGuire

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 56 KB

english, 2004

60

P.3.04 Brain networks in sleep as revealed by combined EEG and fMRI

R. Wehrle, M. Czisch, C. Kaufmann, T.C. Wetter, F. Holsboer, D.P. Auer, T. Pollmächer

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 49 KB

english, 2004

61

P.3.05 In vivo123Iodobenzamide SPECT quantification of striatal dopamine D2 receptor occupancy of risperidone depot in patients with psychosis

G. Wiesegger, N. Klein, T. Attarbaschi, S. Asenbaum, D. Winkler, N. Mossaheb, R. Dudczak, S. Kasper, J. Tauscher

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 57 KB

english, 2004

62

P.3.06 Proline peptidase activities decreased in bipolar disorder not schizophrenia

G. Breen, A.J. Harwood, K. Gregory, M. Sinclair, D. Collier, D. St. Clair, R.S.B. Williams

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 58 KB

english, 2004

63

P.3.07 Chronic daily headache with and without overuse: one or two different psychobiological entities? A study using tridimensional personality Questionnaire

F. Di Stani, G. Bruti, L. Di Clemente, C. Rossi, G.L.L. Lenzi, R. Cerbo, V. Di Piero

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 50 KB

english, 2004

64

P.3.08 Effect of different neurochemicals on peripheral BDNF production

V. Mantua, A.-M. Myint, M. Kubera, M. Maes

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 57 KB

english, 2004

65

P.3.09 Drug-induced hypomania in anxiety disorders

U. Albert, G. Maina, G.E. Maccaferri, F. Bogetto

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 57 KB

english, 2004

66

P.3.10 Combination treatment for panic disorder: a prospective study

C. Bergesio, U. Albert, G. Maina, F. Bogetto

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 47 KB

english, 2004

67

P.3.11 Cognitive function and psychomotor performance in schizophrenic patients

S. Borgwardt, L. Franke, R. Uebelhack

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 55 KB

english, 2004

68

P.3.12 Abnormalities of corpus callosum in schizophrenia: a diffusion-weighted MRI study

P. Brambilla, R. Cerini, A. Gasparini, M. Nosè, E. Vittorini, C. Barbui, A. Versace, N. Andreone, A. David, M.S. Keshavan, C. Procacci, M. Tansella

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 60 KB

english, 2004

69

P.3.13 Neurotrophic and antipsychotic therapy of childhood autism

M.G. Krasnoperova, V.M. Bashina

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 60 KB

english, 2004

70

P.3.14 Depression and epilepsy: searching for the most potent mood stabilisers among antiepileptics

G. Djokic, M. Milenkovic, Lj. Mitrovic

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 56 KB

english, 2004

71

P.3.15 The effect of typical and atypical neuroleptics on working memory in schizophrenic patients

U. Libera, A. Rutkowska, I. Kloszewska

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 46 KB

english, 2004

72

P.3.16 The intensity dependence of the auditory evoked N1-amplitude as a predictor of response to citalopram-treatment in major depression

T. Linka, B. Müller, A. Hesse, S. Bender, G. Sartory

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 53 KB

english, 2004

73

P.3.17 Immunotropic influence of acute or chronic administration of Nootrop on the function of the GABA-ergic system in patients with Major Depression

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 60 KB

english, 2004

74

P.3.18 Rivastigmine therapy for memory deficits in schizophrenia patients receiving electroconvulsive treatment

D. Ophir, F. Bar, R. Stryjer, A. Ullman, R.D. Strous, M. Kotler, A. Weizman

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 58 KB

english, 2004

75

P.3.19 A naturalistic study on quetiapine vs. other mood stabilizers in the treatment of bipolar disorder I and II

G. Tacchini, S. Charitos, S. Fumagalli, O. Fusi, A.C. Altamura

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 51 KB

english, 2004

76

P.3.20 Arrythmic markers affected by clozapine treatment in patients with schizophrenia: heart rate variability, late potentials and QT dispersion

M.N. Tümüklü, K. Alptekin, Ö. Kirmli, Ö. Aslan, B. Kivircik, Ö. Badak, A. Türk, B. Yemez, Y. Akvardar, B. Akdeniz, Ö. Göldeli, S. Güneri, Z. Tunca

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 60 KB

english, 2004

77

P.3.21 A microarray analysis of gene expression pre- and post-lithium treatment in acute mania: molecular signal transduction pathways

L. Kirkby, G. Modi

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 57 KB

english, 2004

78

P.3.22 Prefrontal cortex dysfunction in an animal model for neurodevelopmental psychopathological disorders

L. Diergaarde, L. Groenink, J.M. van Ree

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 43 KB

english, 2004

79

S.4.2 Developmental and non-developmental targets

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 53 KB

english, 2004

80

S.4.01 Stimulation of α1-adrenergic and AMPA receptors in rat medial prefrontal cortex increases local in vivo serotonin release: reversal by antipsychotic drugs

M. Amargós-Bosch, A. Adell, F. Artigas

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 63 KB

english, 2004

81

S.4.02 Dopamine 3 (D3) receptors genetic variants: influence in schizophrenia and antipsychotic response

D. Clark, S. Staddon, I. Mata, D. Mancama, M.J. Arranz, R.W. Kerwin

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 60 KB

english, 2004

82

S.4.03 Long-term administration of olanzapine or clozapine, but not haloperidol, antagonizes the stress-induced increase in dopamine output in the rat prefrontal cortex

L. Dazzi, E. Seu, G. Cherchi, G. Biggio

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 40 KB

english, 2004

83

S.4.04 Brain volume changes in patients with schizophrenia: a 5-year longitudinal MRI study across the age range

N. van Haren, H.E. Hulshoff Pol, W. Cahn, H.G. Schnack, R. Brans, A.J. Laponder, R.S. Kahn

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 47 KB

english, 2004

84

S.4.05 Reduced N-acetyl aspartate levels in the temporal cortex of rats reared in isolation

M. Harte, S.B. Powell, L.M. Reynolds, M.A. Geyer, G.P. Reynolds

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 53 KB

english, 2004

85

S.4.06 An association study of dopaminergic genes in a sample of 283 Dutch schizophrenic patients

M.L.C. Hoogendoorn, S.C. Bakker, H.G. Schnack, H.G. Otten, J.P.C. Selten, P.L. Pearson, R.J. Sinke, R.S. Kahn

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 46 KB

english, 2004

86

S.4.07 Applications of pharmacogenetics and pharmacogenomics in the improvement of psychiatric treatment

D. Mancama, M.J. Arranz, S. Staddon, M. Parsons, D. Clark, S. Osborne, J. Munro, R.W. Kerwin

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 40 KB

english, 2004

87

S.4.08 Temporal and anatomical characterization of stress-related changes on BDNF expression in the rat central nervous system

R. Molteni, F. Fumagalli, M. Roceri, F. Bedogni, F. Cirulli, G. Racagni, M.A. Riva

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 51 KB

english, 2004

88

S.4.09 Endogenous serotonin excites GABAergic neurons of the rat prefrontal cortex through the activation of 5-HT3 receptors

N. Santana, M.V. Puig, P. Celada, G. Mengod, F. Artigas

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 61 KB

english, 2004

89

S.4.10 Modulation of mesocortical dopaminergic system by prefrontal 5-HT2 receptors. Effects of antipsychotic drugs

M.C. Scorza, L. Diaz-Mataix, A. Bortolozzi, P. Celada, F. Artigas

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 54 KB

english, 2004

90

P.4.11 Specific alterations of brain membranes in schizophrenia

G.P. Eckert, E. Schaeffer, A. Schmitt, A. Maras, W.E. Müller, W.F. Gattaz

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 53 KB

english, 2004

91

P.4.12 The relationship between EEG coherence and regional brain metabolism in patients with schizophrenia

K. Espa-Cervena, M. Brunovsky, M. Matousek, V. Krajca, J. Horacek

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 60 KB

english, 2004

92

P.4.13 Is there association between soft signs and clinical picture in schizophrenia?

R. Prikryl, T. Kasparek, H. Kucerova, E. Ceskova

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 55 KB

english, 2004

93

P.4.14 Schizophrenia and bipolar affective disorder possibly linked to chromosome 3q29

A. Schosser, K. Fuchs, F. Leisch, U. Bailer, S. Kasper, W. Sieghart, K. Hornik, H.N. Aschauer

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 48 KB

english, 2004

94

P.4.15 Changes in subunit composition of N-methyl-D-aspartate receptor in animal model of schizophrenia: effect of subunit selective antagonist

I. Skuba, H. Tejkalová, F. Št'astný

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 63 KB

english, 2004

95

P.4.16 GSK-3β in cerebrospinal fluid of schizophrenic patients

N. Kozlovsky, W.T. Regenold, J. Levine, R.H. Belmaker, G. Agam

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 63 KB

english, 2004

96

P.4.17 Pharmacological effects of phencyclidine: dependence on cGMP signaling

E. Pålsson, D. Klamer, J.A. Engel, L. Svensson

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 60 KB

english, 2004

97

P.4.18 Neuroimaging changes in an animal model of schizophrenia

C. Risterucci, K. Jeanneau, S. Schoeppenthau, T. Bielser, B. Kuennecke, M. Von Kienlin, J.L. Moreau

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 47 KB

english, 2004

98

Author index

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 38 KB

english, 2004

99

Keyword index

Journal:

European Neuropsychopharmacology

Year:

2004

Language:

english

File:

PDF, 31 KB

english, 2004